Skip to content

Author

M. A. Chivchyan

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Association of early dapagliflozin initiation with subclinical changes in cardiac function during anticancer therapy

Early dapagliflozin initiation during anthracycline–trastuzumab therapy was associated with better preservation of LV mechanics and LA remodeling over 12 months, and remained within the normal range in both groups throughout follow-up.

L. Hazarapetyan, H. Hayrapetyan, M. A. Chivchyan et al. · 0 citations
Aug 2026

Temporal evolution of subclinical cardiac dysfunction during anticancer treatment in patients with breast cancer

Anticancer treatment is associated with a structured temporal continuum of subclinical cardiac dysfunction, in which early impairment of myocardial deformation is followed by progressive alterations in diastolic mechanics and left atrial structure and function, despite preserved left ventricular ejection fraction.

L. Hazarapetyan, H. Hayrapetyan, P. Zelveian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.